Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$16.27
+3.0%
$18.05
$15.37
$28.00
$10.77B1.236.48 million shs8.02 million shs
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
$26.08
$26.08
$14.10
$26.09
$3.24B0.52633,228 shs1,000 shs
Revvity, Inc. stock logo
RVTY
Revvity
$106.69
+2.3%
$114.20
$97.32
$129.50
$12.82B1.06872,267 shs692,933 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
+3.05%-0.03%+2.46%-23.25%-34.87%
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
0.00%0.00%0.00%0.00%+11.03%
Revvity, Inc. stock logo
RVTY
Revvity
+2.35%-0.68%-3.29%-4.74%+4.37%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.8079 of 5 stars
4.42.00.03.23.32.52.5
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Revvity, Inc. stock logo
RVTY
Revvity
3.4924 of 5 stars
3.42.01.70.03.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.77
Moderate Buy$25.5056.73% Upside
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
0.00
N/AN/AN/A
Revvity, Inc. stock logo
RVTY
Revvity
2.77
Moderate Buy$136.2527.71% Upside

Current Analyst Ratings Breakdown

Latest OLK, RVTY, and AVTR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2025
Avantor, Inc. stock logo
AVTR
Avantor
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/4/2025
Avantor, Inc. stock logo
AVTR
Avantor
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$22.00 ➝ $18.00
2/10/2025
Avantor, Inc. stock logo
AVTR
Avantor
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$27.00 ➝ $25.00
2/10/2025
Avantor, Inc. stock logo
AVTR
Avantor
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$26.00 ➝ $24.00
2/10/2025
Avantor, Inc. stock logo
AVTR
Avantor
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$33.00 ➝ $31.00
2/10/2025
Avantor, Inc. stock logo
AVTR
Avantor
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$28.00 ➝ $25.00
2/10/2025
Avantor, Inc. stock logo
AVTR
Avantor
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $26.00
2/10/2025
Avantor, Inc. stock logo
AVTR
Avantor
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$26.00 ➝ $23.00
2/3/2025
Avantor, Inc. stock logo
AVTR
Avantor
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$25.00 ➝ $26.00
2/3/2025
Revvity, Inc. stock logo
RVTY
Revvity
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$135.00 ➝ $140.00
2/3/2025
Revvity, Inc. stock logo
RVTY
Revvity
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$140.00 ➝ $145.00
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.78B1.63$1.51 per share10.76$8.75 per share1.86
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
$170.89M18.98N/AN/A$4.04 per share6.46
Revvity, Inc. stock logo
RVTY
Revvity
$2.76B4.65$7.92 per share13.47$63.00 per share1.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$711.50M$1.0415.6413.561.5510.49%12.17%5.38%4/25/2025 (Estimated)
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
-$31.60M-$0.27N/A1,304.00N/A-19.72%-7.07%-6.05%N/A
Revvity, Inc. stock logo
RVTY
Revvity
$270.39M$2.2148.2819.193.829.81%7.68%4.62%5/5/2025 (Estimated)

Latest OLK, RVTY, and AVTR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2025N/A
Avantor, Inc. stock logo
AVTR
Avantor
$0.23N/AN/AN/A$1.61 billionN/A
2/12/2025Q4 24
Avantor, Inc. stock logo
AVTR
Avantor
$0.26$0.27+$0.01$0.73$1.71 billionN/A
1/31/2025Q4 24
Revvity, Inc. stock logo
RVTY
Revvity
$1.37$1.42+$0.05$0.78$730.04 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
N/AN/AN/AN/AN/A
Revvity, Inc. stock logo
RVTY
Revvity
$0.280.26%N/A12.67%N/A

Latest OLK, RVTY, and AVTR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/23/2025
Revvity, Inc. stock logo
RVTY
Revvity
quarterly$0.070.23%4/17/20254/18/20255/9/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
0.54
1.07
0.70
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
N/A
5.60
3.91
Revvity, Inc. stock logo
RVTY
Revvity
0.41
3.60
3.03

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
30.19%
Revvity, Inc. stock logo
RVTY
Revvity
86.65%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.50%
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
5.20%
Revvity, Inc. stock logo
RVTY
Revvity
0.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
14,500681.40 million672.05 millionOptionable
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
420124.34 million117.88 millionOptionable
Revvity, Inc. stock logo
RVTY
Revvity
11,500120.15 million120.97 millionOptionable

Recent News About These Companies

Brokerages Set Revvity, Inc. (NYSE:RVTY) Target Price at $136.25
Revvity announces FDA approval for Auto-Pure 2400 liquid handling platform
1 Healthcare Stock to Target This Week and 2 to Turn Down

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avantor stock logo

Avantor NYSE:AVTR

$16.27 +0.47 (+2.97%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$16.18 -0.09 (-0.52%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Olink Holding AB (publ) stock logo

Olink Holding AB (publ) NASDAQ:OLK

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Revvity stock logo

Revvity NYSE:RVTY

$106.69 +2.38 (+2.28%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$103.00 -3.69 (-3.46%)
As of 06:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.